Arne Ylinen - Publications

University of Kuopio, Finland, Kuopio, Finland 

76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Isokuortti H, Luoto TM, Kataja A, Brander A, Siironen J, Liimatainen S, Iverson GL, Ylinen A, Ohman J. Necessity of monitoring after negative head CT in acute head injury. Injury. 45: 1340-4. PMID 24810669 DOI: 10.1016/j.injury.2014.04.012  0.76
2014 Koskinen EA, Hakulinen U, Brander AE, Luoto TM, Ylinen A, Ohman JE. Clinical correlates of cerebral diffusion tensor imaging findings in chronic traumatic spinal cord injury. Spinal Cord. 52: 202-8. PMID 24418961 DOI: 10.1038/sc.2013.163  0.76
2013 Koskinen E, Brander A, Hakulinen U, Luoto T, Helminen M, Ylinen A, Ohman J. Assessing the state of chronic spinal cord injury using diffusion tensor imaging. Journal of Neurotrauma. 30: 1587-95. PMID 23758292 DOI: 10.1089/neu.2013.2943  0.76
2010 Hartikainen KM, Waljas M, Isoviita T, Dastidar P, Liimatainen S, Solbakk AK, Ogawa KH, Soimakallio S, Ylinen A, Ohman J. Persistent symptoms in mild to moderate traumatic brain injury associated with executive dysfunction. Journal of Clinical and Experimental Neuropsychology. 32: 767-74. PMID 20198531 DOI: 10.1080/13803390903521000  0.76
2010 Söderholm S, Lehtinen A, Valtonen K, Ylinen A. Dysphagia and dysphonia among persons with post-polio syndrome - a challenge in neurorehabilitation. Acta Neurologica Scandinavica. 122: 343-9. PMID 20055768 DOI: 10.1111/j.1600-0404.2009.01315.x  0.76
2009 Rossi M, Dastidar P, Ryymin P, Ylinen A, Öhman J, Soimakallio S, Eskola H. Image quality and signal distribution in 1.5-T and 3-T MRI in mild traumatic brain injury patients Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7258. DOI: 10.1117/12.812224  0.76
2008 Liimatainen SP, Raitanen JA, Ylinen AM, Peltola MA, Peltola JT. The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 808-12. PMID 17991701 DOI: 10.1136/jnnp.2007.132811  0.76
2008 Liimatainen SP, Raitanen JA, Ylinen AM. The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy (Journal of Neurology, Neurosurgery and Psychiatry (2008) 79, (808-812)) Journal of Neurology, Neurosurgery and Psychiatry. 79: 1086. DOI: 10.1136/jnnp.2007.132811corr1  0.76
2005 Yavich L, Ylinen A. Spreading depression in the cortex differently modulates dopamine release in rat mesolimbic and nigrostriatal terminal fields. Experimental Neurology. 196: 47-53. PMID 16084513 DOI: 10.1016/j.expneurol.2005.07.005  0.76
2004 Kalueff AV, Lehtimaki KA, Ylinen A, Honkaniemi J, Peltola J. Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neuroscience Letters. 365: 106-10. PMID 15245788 DOI: 10.1016/j.neulet.2004.04.061  0.76
2004 Immonen A, Jutila L, Kälviäinen R, Mervaala E, Partanen K, Partanen J, Vanninen R, Ylinen A, Alafuzoff I, Paljärvi L, Hurskainen H, Rinne J, Puranen M, Vapalahti M. Preoperative clinical evaluation, outline of surgical technique and outcome in temporal lobe epilepsy. Advances and Technical Standards in Neurosurgery. 29: 87-132. PMID 15035337  0.76
2004 Gureviciene I, Ikonen S, Gurevicius K, Sarkaki A, van Groen T, Pussinen R, Ylinen A, Tanila H. Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice. Neurobiology of Disease. 15: 188-95. PMID 15006688 DOI: 10.1016/j.nbd.2003.11.011  0.76
2003 Immonen A, Jutila L, Könönen M, Mervaala E, Partanen J, Puranen M, Rinne J, Ylinen A, Vapalahti M. 3-D reconstructed magnetic resonance imaging in localization of subdural EEG electrodes. Case illustration. Epilepsy Research. 54: 59-62. PMID 12742597 DOI: 10.1016/S0920-1211(03)00038-X  0.76
2003 Karhunen H, Pitkänen A, Virtanen T, Gureviciene I, Pussinen R, Ylinen A, Sivenius J, Nissinen J, Jolkkonen J. Long-term functional consequences of transient occlusion of the middle cerebral artery in rats: a 1-year follow-up of the development of epileptogenesis and memory impairment in relation to sensorimotor deficits. Epilepsy Research. 54: 1-10. PMID 12742590 DOI: 10.1016/S0920-1211(03)00034-2  0.76
2003 Pitkänen A, Savander M, Nurminen N, Ylinen A. Intrinsic synaptic circuitry of the amygdala. Annals of the New York Academy of Sciences. 985: 34-49. PMID 12724146  0.76
2003 Yavich L, Sirviö J, Haapalinna A, Ylinen A, Männistö PT. Atipamezole, an alpha2-adrenoceptor antagonist, augments the effects of L-DOPA on evoked dopamine release in rat striatum. European Journal of Pharmacology. 462: 83-9. PMID 12591099 DOI: 10.1016/S0014-2999(03)01324-4  0.76
2003 Gureviciene I, Puoliväli J, Pussinen R, Wang J, Tanila H, Ylinen A. Estrogen treatment alleviates NMDA-antagonist induced hippocampal LTP blockade and cognitive deficits in ovariectomized mice. Neurobiology of Learning and Memory. 79: 72-80. PMID 12482681 DOI: 10.1016/S1074-7427(02)00012-6  0.76
2002 Jutila L, Immonen A, Mervaala E, Partanen J, Partanen K, Puranen M, Kälviäinen R, Alafuzoff I, Hurskainen H, Vapalahti M, Ylinen A. Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients. Journal of Neurology, Neurosurgery, and Psychiatry. 73: 486-94. PMID 12397139 DOI: 10.1136/jnnp.73.5.486  0.76
2002 Arabadzisz D, Ylinen A, Emri Z. Increased inter-spike intervals and fast after-hyperpolarization of action potentials in rat hippocampal pyramidal cells accompanied with altered calbindin immunoreactivity 10-12 months after global forebrain ischemia. Neuroscience Letters. 331: 103-6. PMID 12361851 DOI: 10.1016/S0304-3940(02)00864-9  0.76
2002 Jutila L, Immonen A, Partanen K, Partanen J, Mervaala E, Ylinen A, Alafuzoff I, Paljärvi L, Karkola K, Vapalahti M, Pitkänen A. Neurobiology of epileptogenesis in the temporal lobe. Advances and Technical Standards in Neurosurgery. 27: 5-22. PMID 11887582  0.76
2001 Jutila L, Ylinen A, Partanen K, Alafuzoff I, Mervaala E, Partanen J, Vapalahti M, Vainio P, Pitkänen A. MR volumetry of the entorhinal, perirhinal, and temporopolar cortices in drug-refractory temporal lobe epilepsy. Ajnr. American Journal of Neuroradiology. 22: 1490-501. PMID 11559496  0.76
2001 Lamusuo S, Jutila L, Ylinen A, Kälviäinen R, Mervaala E, Haaparanta M, Jääskeläinen S, Partanen K, Vapalahti M, Rinne J. [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage. Archives of Neurology. 58: 933-9. PMID 11405808  0.76
2000 Partanen J, Partanen K, Ylinen A, Mervaala E, HerrgÃ¥rd E, Vapalahti M. [Defining the epileptogenic focus]. Duodecim; LääKetieteellinen Aikakauskirja. 116: 396-407. PMID 11787092  0.76
2000 Pitkänen A, Nissinen J, Lukasiuk K, Jutila L, Paljärvi L, Salmenperä T, Karkola K, Vapalahti M, Ylinen A. Association between the density of mossy fiber sprouting and seizure frequency in experimental and human temporal lobe epilepsy. Epilepsia. 41: S24-9. PMID 10999515  0.76
2000 Pitkänen A, Pikkarainen M, Nurminen N, Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Annals of the New York Academy of Sciences. 911: 369-91. PMID 10911886  0.76
2000 Lamusuo S, Pitkänen A, Jutila L, Ylinen A, Partanen K, Kälviäinen R, Ruottinen HM, Oikonen V, NÃ¥gren K, Lehikoinen P, Vapalahti M, Vainio P, Rinne JO. [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology. 54: 2252-60. PMID 10881249  0.76
2000 Baumgartner C, Brazdil M, Binnie C, De la Lande O, Dam M, Munari C, Majkowski J, Polkey C, Russi A, Schramm J, Stefan H, Wieser HG, Ylinen A. Pre-surgical evaluation for epilepsy surgery - European standards: European Federation of Neurological Societies Task Force European Journal of Neurology. 7: 119-122. PMID 10809927 DOI: 10.1046/j.1468-1331.2000.00004.x  0.76
1999 Lamusuo S, Forss N, Ruottinen HM, Bergman J, Mäkelä JP, Mervaala E, Solin O, Rinne JK, Ruotsalainen U, Ylinen A, Vapalahti M, Hari R, Rinne JO. [18F]FDG-PET and whole-scalp MEG localization of epileptogenic cortex. Epilepsia. 40: 921-30. PMID 10403216 DOI: 10.1111/j.1528-1157.1999.tb00799.x  0.76
1999 Ylinen A, Salmenperä T, Mumford JP, Riekkinen PJ. Long-term treatment with vigabatrin - 10 years of clinical experience. Seizure. 8: 181-3. PMID 10356378 DOI: 10.1053/seiz.1998.0260  0.76
1999 Lauri SE, Kaukinen S, Kinnunen T, Ylinen A, Imai S, Kaila K, Taira T, Rauvala H. Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 1226-35. PMID 9952400  0.76
1998 Ylinen A. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability. Journal of Intellectual Disability Research : Jidr. 42: 46-9. PMID 10030432  0.76
1998 Mikkonen M, Soininen H, Kälviänen R, Tapiola T, Ylinen A, Vapalahti M, Paljärvi L, Pitkänen A. Remodeling of neuronal circuitries in human temporal lobe epilepsy: increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex. Annals of Neurology. 44: 923-34. PMID 9851437 DOI: 10.1002/ana.410440611  0.76
1997 Ylinen A, Sirviö J. [The biological basis of memory]. Duodecim; LääKetieteellinen Aikakauskirja. 113: 1729-36. PMID 10892064  0.76
1997 Lamusuo S, Ruottinen HM, Knuuti J, Härkönen R, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Mervaala E, Nousiainen U, Jääskeläinen S, Ylinen A, Kälviäinen R, Rinne JK, Vapalahti M, et al. Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. Journal of Neurology, Neurosurgery, and Psychiatry. 63: 743-8. PMID 9416808  0.76
1996 Lahtinen H, Ylinen A, Lukkarinen U, Sirviö J, Miettinen R, Riekkinen P. Failure of carbamazepine to prevent behavioural and histopathological sequels of experimentally induced status epilepticus. European Journal of Pharmacology. 297: 213-8. PMID 8666052 DOI: 10.1016/0014-2999(95)00742-3  0.76
1996 Salmenperä T, Kälviäinen R, Ylinen A, Riekkinen PJ. Cost of epilepsy: Review of the literature Neurologist. 2: 230-238.  0.76
1995 Ylinen A, Bragin A, Nádasdy Z, Jandó G, Szabó I, Sik A, Buzsáki G. Sharp wave-associated high-frequency oscillation (200 Hz) in the intact hippocampus: network and intracellular mechanisms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 30-46. PMID 7823136  0.76
1995 Ylinen A, Soltész I, Bragin A, Penttonen M, Sik A, Buzsáki G. Intracellular correlates of hippocampal theta rhythm in identified pyramidal cells, granule cells, and basket cells. Hippocampus. 5: 78-90. PMID 7787949 DOI: 10.1002/hipo.450050110  0.76
1995 Ylinen A, Pitkänen M, Sirviö J, Hartikainen T, Sivenius J, Koivisto E, Riekkinen PJ. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. European Journal of Pharmacology. 274: 159-65. PMID 7768268 DOI: 10.1016/0014-2999(94)00729-Q  0.76
1995 Turner DA, Li XG, Pyapali GK, Ylinen A, Buzsaki G. Morphometric and electrical properties of reconstructed hippocampal CA3 neurons recorded in vivo. The Journal of Comparative Neurology. 356: 580-94. PMID 7560268 DOI: 10.1002/cne.903560408  0.76
1995 Pitkänen M, Sirviö J, Ylinen A, Koivisto E, Riekkinen P. Effects of NMDA receptor modulation on hippocampal type 2 theta activity in rats. General Pharmacology. 26: 1065-70. PMID 7557252 DOI: 10.1016/0306-3623(94)00268-R  0.76
1995 Ylinen A, Kälviäinen R, Riekkinen PJ. Long-term efficacy and cognitive effects of vigabatrin. Acta Neurologica Scandinavica. Supplementum. 162: 47-50. PMID 7495191  0.76
1995 Sik A, Penttonen M, Ylinen A, Buzsáki G. Hippocampal CA1 interneurons: an in vivo intracellular labeling study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 6651-65. PMID 7472426  0.76
1994 Li XG, Somogyi P, Ylinen A, Buzsáki G. The hippocampal CA3 network: an in vivo intracellular labeling study. The Journal of Comparative Neurology. 339: 181-208. PMID 8300905 DOI: 10.1002/cne.903390204  0.76
1994 Sik A, Ylinen A, Penttonen M, Buzsáki G. Inhibitory CA1-CA3-hilar region feedback in the hippocampus. Science (New York, N.Y.). 265: 1722-4. PMID 8085161  0.76
1994 Sivenius J, Ylinen A, Kälviäinen R, Riekkinen PJ. Long-term study with gabapentin in patients with drug-resistant epileptic seizures. Archives of Neurology. 51: 1047-50. PMID 7945002 DOI: 10.1001/archneur.1994.00540220095019  0.76
1993 Pitkänen A, Ylinen A, Matilainen R, Luukkainen R, Mervaala E, Seppänen R, Ruutiainen T, Riekkinen PJ. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study. Archives of Neurology. 50: 24-9. PMID 8418797 DOI: 10.1001/archneur.1993.00540010020012  0.76
1993 Lahtinen H, Korhonen E, Castrén E, Miettinen R, Ylinen A, Riekkinen PJ. Long-term alterations in NMDA-sensitive L-[3H]glutamate binding in the rat hippocampus following fimbria-fornix lesioning. Experimental Neurology. 121: 193-9. PMID 8339770 DOI: 10.1006/exnr.1993.1086  0.76
1993 Lahtinen H, Miettinen R, Ylinen A, Halonen T, Riekkinen PJ. Biochemical and morphological changes in the rat hippocampus following transection of the fimbria-fornix. Brain Research Bulletin. 31: 311-8. PMID 8098258 DOI: 10.1016/0361-9230(93)90223-X  0.76
1993 Lahtinen H, Castrén E, Miettinen R, Ylinen A, Paljärvi L, Riekkinen PJ. NMDA-sensitive [3H]glutamate binding in the epileptic rat hippocampus: an autoradiographic study. Neuroreport. 4: 45-8. PMID 8095822  0.76
1993 Lahtinen H, Ylinen A, Hyvönen M, Sirviö J, Miettinen R, Riekkinen PJ. Preservation of hippocampal NMDA receptors may be crucial for spatial learning after epileptic seizures in rats. Brain Research. 625: 93-9. PMID 7902194 DOI: 10.1016/0006-8993(93)90141-9  0.76
1992 Ylinen A, Koivisto E, Valjakka A, Sirviö J, Freund TF, Riekkinen P. Hippocampal mobility-related theta activity is not diminished by vigabatrin, a GABAmimetic antiepileptic drug, in normal rats. Brain Research Bulletin. 28: 145-7. PMID 1540842 DOI: 10.1016/0361-9230(92)90242-P  0.76
1992 Ylinen A, Sivenius J, Pitkänen A, Halonen T, Partanen J, Mervaala E, Mumford JP, Riekkinen PJ. Gamma-vinyl GABA (vigabatrin) in epilepsy: clinical, neurochemical, and neurophysiologic monitoring in epileptic patients. Epilepsia. 33: 917-22. PMID 1396436 DOI: 10.1111/j.1528-1157.1992.tb02201.x  0.76
1992 Freund TF, Ylinen A, Miettinen R, Pitkänen A, Lahtinen H, Baimbridge KG, Riekkinen PJ. Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability. Brain Research Bulletin. 28: 27-38. PMID 1347249 DOI: 10.1016/0361-9230(92)90227-O  0.76
1991 Sirviö J, Ylinen A, Lahtinen H, Ronkainen A, Riekkinen P, Halonen T, Riekkinen PJ. The effect of subchronic administration of vigabatrin on learning and memory in nonepileptic rats. Pharmacology, Biochemistry, and Behavior. 39: 205-10. PMID 1924505 DOI: 10.1016/0091-3057(91)90423-Y  0.76
1991 Sivenius J, Kälviäinen R, Ylinen A, Riekkinen P. Double-blind study of Gabapentin in the treatment of partial seizures. Epilepsia. 32: 539-42. PMID 1907907  0.76
1991 Sivenius J, Ylinen A, Murros K, Mumford JP, Riekkinen PJ. Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study. Neurology. 41: 562-5. PMID 1901397  0.76
1991 Ylinen A, Lahtinen H, Sirviö J, Partanen J, Asikainen A, Gulyas A, Freund TF, Riekkinen P. Behavioural, electrophysiological and histopathological changes following sustained stimulation of the perforant pathway input to the hippocampus: effect of the NMDA receptor antagonist, CGP 39551. Brain Research. 553: 195-200. PMID 1681982 DOI: 10.1016/0006-8993(91)90824-F  0.76
1991 Ylinen A, Valjakka A, Lahtinen H, Miettinen R, Freund TF, Riekkinen P. Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path. Neuropeptides. 19: 205-11. PMID 1680224 DOI: 10.1016/0143-4179(91)90120-8  0.76
1991 Ylinen AM, Miettinen R, Pitkänen A, Gulyas AI, Freund TF, Riekkinen PJ. Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy. Proceedings of the National Academy of Sciences of the United States of America. 88: 7650-3. PMID 1652757  0.76
1991 Sivenius J, Ylinen A, Riekkinen PJ. Reply from the authors: Vigabatrin treatment of epilepsy Neurology. 41: 1855.  0.76
1989 Nousiainen U, Mervaala E, Ylinen A, Uusitupa M, Riekkinen P. The importance of the electrocardiogram in ambulatory electroencephalographic recordings. Archives of Neurology. 46: 1171-4. PMID 2818252 DOI: 10.1001/archneur.1989.00520470025019  0.76
1989 Riekkinen PJ, Pitkanen A, Ylinen A, Sivenius J, Halonen T. Specificity of vigabatrin for the GABAergic system in human epilepsy. Epilepsia. 30: S18-22. PMID 2767015  0.76
1989 Riekkinen PJ, Ylinen A, Halonen T, Sivenius J, Pitkanen A. Cerebrospinal fluid GABA and seizure control with vigabatrin. British Journal of Clinical Pharmacology. 27: 87S-94S. PMID 2757914  0.76
1989 Nousiainen U, Mervaala E, Uusitupa M, Ylinen A, Sivenius J. Cardiac arrhythmias in the differential diagnosis of epilepsy. Journal of Neurology. 236: 93-6. PMID 2709059 DOI: 10.1007/BF00314403  0.76
1989 Pitkänen A, Lepola U, Ylinen A, Riekkinen PJ. Somatostatin and beta-endorphin levels in cerebrospinal fluid of nonmedicated and medicated patients with epileptic seizures. Neuropeptides. 13: 9-15. PMID 2564169 DOI: 10.1016/0143-4179(89)90015-2  0.76
1988 Sivenius J, Heinonen E, Lehto H, Järvensivu P, Anttila M, Ylinen A, Riekkinen P. Reduction of dosing frequency of carbamazepine with a slow-release preparation. Epilepsy Research. 2: 32-6. PMID 3197677 DOI: 10.1016/0920-1211(88)90007-1  0.76
1988 Nousiainen U, Ylinen A, Uusitupa M, Mervaala E, Sivenius J. [The differential diagnosis of cardiac arrhythmias and epilepsy]. Duodecim; LääKetieteellinen Aikakauskirja. 104: 266-70. PMID 3168835  0.76
1988 Lepola U, Nousiainen U, Ylinen A. [Psychogenic seizures in an epileptic patient]. Duodecim; LääKetieteellinen Aikakauskirja. 104: 1257-9. PMID 3168825  0.76
1988 Sivenius J, Pitkänen A, Matilainen R, Ylinen A, Holonen T, Partanen J, Riekkinen PJ. Studies on gamma-vinyl-GABA in Kuopio, Finland. British Journal of Clinical Practice. Supplement. 61: 31-2. PMID 3145775  0.76
1988 Halonen T, Lehtinen M, Pitkänen A, Ylinen A, Riekkinen PJ. Inhibitory and excitatory amino acids in CSF of patients suffering from complex partial seizures during chronic treatment with gamma-vinyl GABA (vigabatrin). Epilepsy Research. 2: 246-52. PMID 3143562 DOI: 10.1016/0920-1211(88)90015-0  0.76
1988 Riekkinen PJ, Pitkänen A, Halonen T, Lehtinen M, Ylinen A, Sivenius J. Effect of gamma-vinyl GABA treatment on cholinergic and aminergic neurotransmission and on cyclic nucleotides in human complex partial epilepsy--a CSF study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 81-91. PMID 2452456 DOI: 10.1016/0278-5846(88)90063-2  0.76
1987 Pitkänen A, Riekkinen PJ, Halonen T, Ylinen A, Ruutiainen T, Lehtinen M. Amino acid levels in human CSF after generalized seizure. Journal of Neural Transmission. 70: 313-9. PMID 3681287 DOI: 10.1007/BF01253605  0.76
1987 Sivenius MR, Ylinen A, Murros K, Matilainen R, Riekkinen P. Double-blind dose reduction study of vigabatrin in complex partial epilepsy. Epilepsia. 28: 688-92. PMID 3319536  0.76
1987 Pitkänen A, Halonen T, Ylinen A, Riekkinen P. Somatostatin, beta-endorphin, and prolactin levels in human cerebrospinal fluid during the gamma-vinyl-GABA treatment of patients with complex partial epilepsy. Neuropeptides. 9: 185-95. PMID 2885776 DOI: 10.1016/0143-4179(87)90038-2  0.76
1986 Jolkkonen J, Soininen H, Halonen T, Ylinen A, Laulumaa V, Laakso M, Riekkinen P. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 49: 1374-7. PMID 2433403 DOI: 10.1136/jnnp.49.12.1374  0.76
Show low-probability matches.